Latest News

Arash Mostaghimi, MD, MPH, FAAD, and experts discuss evolving treatment standards for alopecia areata, focusing on JAK inhibitors, patient-centered care, and future therapeutic innovations.

Discover how a proprietary extract from saw palmetto promotes hair growth and reduces thinning in adults, offering a safe alternative to traditional treatments.

The study provides new evidence beyond previously established associations with breast, ovarian, and uterine cancers.

Navigator Medicines advances NAV-240, a promising bispecific antibody for HS, targeting dual pathways for enhanced treatment efficacy.

This review of the latest dermatologic studies includes a new instrument to measure QoL in pediatric alopecia, BTX-A in patients with recessive dystrophic epidermolysis bullosa, eosinophilic pustular folliculitis in children, and more.

However, over half of the patients reported experiencing psychological symptoms such as mood changes and depression during treatment.

Citius Oncology’s IL-2 receptor–directed fusion protein offers rapid responses and pruritus improvement for relapsed or refractory stage I–III CTCL.

Participants agreed that HS is rarely controlled with monotherapy and often requires coordinated multimodal care.

Support vital dermatology organizations this Giving Tuesday and beyond to enhance patient care, drive research, and foster community.

Mondana Ghias, MD, FAAD, offers strategies for dermatologists in managing skin reactions from lung cancer treatments to enhance patient care and quality of life.

While individual fatty acids in tallow have known biological effects, their combined impact in whole tallow remains uncertain.

Arcutis is advancing pediatric dermatology with innovative, steroid-sparing treatments for atopic dermatitis and plaque psoriasis, enhancing care for young patients.

Nayan Patel, PharmD, is revolutionizing skin rejuvenation with advanced delivery technology of GHK-Cu for youthful vitality.